therapeutic device News
-
In the hands of ADAMO Robot
The clinical trials conducted by La Rioja’s healthcare service demonstrates the effectiveness of the only therapeutic massage robotic device that uses pressurized air to treat back pain. ...
By Adamo Robot
-
Italian excellence in the treatment of ulcers and wounds
Since its foundation in June 2011, THERESON has combined research and technological and scientific development with the business idea. THERESON believes that technology can be a complementary aid to the treatment and treatment of acute and chronic pathologies. However, it is necessary that each therapeutic medical device is designed in response to the specific needs of the patient, doctor and ...
-
NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will be featured as a presenting company at the H.C. Wainwright BioConnect Virtual Conference to be held January 10-13, 2022. Brian Murphy, Chief Executive Officer of NanoVibronix, will provide an ...
By NanoVibronix
-
Reflow Medical Announces 510(K) Clearance For An Expanded Indication For The Wingman Catheter To Cross Chronic Total Occlusions (CTOs) In Peripheral Artery Disease
Reflow Medical, Inc., a California-based medical device company, has announced that they have received clearance from the FDA for an expanded indication for the Wingman™ Crossing Catheter after completing the Wing-IT clinical trial. The Wingman Catheter crosses peripheral CTOs using an extendable beveled tip that creates a channel to help penetrate, or cross, the occlusion with a guidewire, ...
-
Enrollment Completed In Reflow Medical’s DEEPER OUS Clinical Trial
Reflow Medical, Inc. announces that it has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company’s Temporary Spur Stent System, a novel device that features a retrievable stent designed for complex infrapopliteal disease. 106 patients have now been enrolled in the prospective, nonrandomized trial in multiple centers in Europe and New Zealand. Intended ...
-
Reflow Medical Receives Approval In Japan For The Wingman Catheter To Cross Chronic Total Occlusions (CTOs) In Peripheral Artery Disease
Reflow Medical, Inc., a California- based medical device company, announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved the Wingman™ CTO Catheter. Reflow Medical has partnered with Century Medical, Inc. (CMI), a leading medical device distributor based in Tokyo, to introduce the Wingman CTO Catheter in Japan. The Wingman Catheter crosses peripheral ...
-
BrainQ gets FDA Breakthrough status for its device for reducing disability following stroke
JERUSALEM, Feb. 11, 2021-- BrainQ, the Israeli start-up with a therapeutic solution to reduce disability following stroke, announced today that the United States Food and Drug Administration (FDA) has designated its AI-powered technology as a Breakthrough Device. The designation, which was based on BrainQ's latest randomized controlled clinical trial results for ischemic stroke patients, ...
-
NanoVibronix Extends Reach of UroShield and PainShield through MTSG`s International Network
NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed an International Marketing, Sales and Clinical Management Agreement with Medtech Solutions Group (“MTSG”), a leader in the commercialization of healthcare technologies. The ...
By NanoVibronix
-
Cerus Endovascular Receives CE Mark Approval for its Contour 021 device
Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its state of the art CerusEndo MC 021 microcatheter, designed to allow physicians to access tortuous neurovasculature and deliver therapeutic devices to intended targets. “We remain committed to meeting the ever-increasing needs of the interventional ...
-
Infuseon Therapeutics Earns FDA Clearance for Novel Central Nervous System Delivery Device
Infuseon Therapeutics’ novel central nervous system deliver device has received FDA 510(k) clearance as a therapeutic delivery device. Infuseon Therapeutics’ Cleveland Multiport CatheterTM (CMC), a multiport convection-enhanced delivery catheter, was designed by neurosurgeon Michael Vogelbaum, MD, PhD, from Cleveland Clinic’s Brain Tumor and NeuroOncology Center and Department ...
-
FDA Approves Theranica`s Nerivio® for Acute Treatment of Migraine in Adolescents
Theranica, a prescribed digital therapeutics (PDT) company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio® therapeutic device has received the Food and Drug Administration clearance to market for an expanded indication for acute treatment of episodic or chronic migraine in people 12 years and older. The use of the device in the ...
-
Fibralign Selected as a UCSF Rosenman Institute Innovator
The UCSF Rosenman Institute is proud to announce the 2021 cohort of the Rosenman Innovators, a group of early-stage health technology companies chosen for their innovative technologies and patient impact. 2021 is the sixth year for the Rosenman Innovator selection cycle, which has the goal of identifying promising companies seeking funding from seed stage to Series A. The number of companies ...
-
Atmo Biosciences wins Early Stage Investment Forum at AusBiotech
Atmo Biosciences beat 10 other contenders to win the Early Stage Investment Forum (ESIF) at AusBiotech 2019, held at the Melbourne Convention Centre last week. The ESIF is a key element of the annual AusBiotech conference featuring short pitches from SMEs and research institutions on early stage biotech technology and projects covering areas such as: Human therapeutics Diagnostics Medical ...
-
The UCSF Rosenman Institute Announces the 2021 Rosenman Innovators
SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- The UCSF Rosenman Institute is proud to announce the 2021 cohort of the Rosenman Innovators, a group of early-stage health technology companies chosen for their innovative technologies and patient impact. 2021 is the sixth year for the Rosenman Innovator selection cycle, which has the goal of identifying promising companies seeking funding from seed ...
-
NeoTherma Oncology Raises $6 Million to Advance VectRx to Human Testing
NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the closing of a $6 million capital raise. The financing provides the resources to conduct human testing of NTO's VectRx™ thermal oncology treatment platform, designated by FDA as a 'Breakthrough Therapy' for Pancreatic Cancer, expediting patient access ...
-
Scion Medical Limited Acquired B. Braun VascuFlex Family of Products
December 19, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC, announced today that it parent company Scion Medical Limited has acquired a portfolio of peripheral interventional radiology products, including 36 global patents, from B. Braun. The portfolio consists of the VascuFlex® family of stent products currently marketed globally, a distal protection device and an ...
-
V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure
V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device Designation for its interatrial shunt for Heart Failure (HF). V-Wave’s minimally invasive, implanted interatrial shunt is being evaluated in a global, randomized, ...
By V-Wave Ltd.
-
Aerami Therapeutics to Present at the LifeSci Partners Summer Symposium
Aerami Therapeutics, Inc. (the “Company”) announced today that Anne Whitaker, Chief Executive Officer, will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners, on August 4 and 5, 2020. Please click the following link to register Presentation Details: Date: August 5, 2020 Time: 9:00 am Eastern Time About Aerami ...
-
Fibralign Announces CE Mark Approval for BioBridge
Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first product, the BioBridge Collagen Matrix. BioBridge is classified as a Class III device with an indication for use to support lymphatic tissue repair and can be used after or in conjunction with surgical procedures addressing lymphedema. CE mark is a ...
-
Oncomfort receives ISO 13485:2016 certification
ncomfort, the leader in Digital Sedation™, a digital therapy to relieve patient anxiety and pain, today announces that it has obtained the ISO 13485:2016 certification by certification company DARE!! Services. This certification confirms that Oncomfort manages the design, manufacturing and distribution of its Digital Sedation™ medical device and its Sedakit™, in its quality ...
By Oncomfort
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you